Institute for Pathology, Academic Teaching Hospital Feldkirch, Feldkirch, Austria.
J Clin Pathol. 2012 Jul;65(7):619-23. doi: 10.1136/jclinpath-2011-200552. Epub 2012 May 3.
Extramural venous invasion (EVI) is an important predictor of haematogenous metastasis in colorectal cancer (CRC). However, remarkable discrepancies in incidence rates indicate major problems regarding EVI assessment. The present prospective study applies tangential vessel preparation to CRC resection specimens and correlates results of EVI with metachronous haematogenous metastatic (MHM) spread.
Stage II CRC diagnosed at the Institute of Pathology, University Teaching Hospital Feldkirch, Austria over a period of 30 months were analysed and tangential sectioning of the pericolonic tissue was performed. Confirmation, or exclusion of MHM, as assessed by computerised tomography, sonography or biopsy, was recorded.
In 50/79 (63%) cases EVI was detected. In 13/50 (26%), MHM developed. Of the 29/79 (37%) patients without EVI, only one (3.5%) developed MHM. Statistically, the rate of MHM for patients with EVI was independent of adjuvant chemotherapy.
Tangential sectioning of the tumour periphery in CRC stage II yields a high rate of histologically evaluable extramural veins and permits proper assessment of EVI. Absence of EVI is significantly associated with metastasis-free survival, a finding of potential therapeutic value. On the other hand, one-third of the patients with EVI and circumferential tumour growth develop MHM, a setting in which the option for adjuvant chemotherapy should be considered. This study emphasises the importance of tangential sectioning of the invasive tumour front in CRC compared with the recommended perpendicular technique. The sensitivity and specificity of this method regarding MHM are characterised.
外膜静脉侵犯(EVI)是结直肠癌(CRC)血行转移的重要预测因子。然而,发生率的显著差异表明在 EVI 评估方面存在重大问题。本前瞻性研究将切线血管准备应用于 CRC 切除标本,并将 EVI 结果与异时性血行转移性(MHM)扩散相关联。
分析在奥地利菲尔德基希大学教学医院病理学研究所诊断为 II 期 CRC 的患者,并进行结肠旁组织的切线切片。通过计算机断层扫描、超声或活检评估 MHM 的确认或排除。
在 79 例患者中有 50 例(63%)检测到 EVI。在 50 例中有 13 例(26%)发生 MHM。在 29 例无 EVI 的患者中,只有 1 例(3.5%)发生 MHM。统计学上,EVI 患者的 MHM 发生率与辅助化疗无关。
CRC II 期肿瘤外周的切线切片可获得高比例的可评估的外膜静脉,并可对 EVI 进行适当评估。无 EVI 与无转移生存率显著相关,这一发现具有潜在的治疗价值。另一方面,三分之一的 EVI 患者和环周肿瘤生长患者发生 MHM,在此情况下应考虑辅助化疗的选择。与推荐的垂直技术相比,本研究强调了在 CRC 中对肿瘤侵袭前沿进行切线切片的重要性。该方法在评估 MHM 方面的敏感性和特异性特征。